Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM8 | Q7Z2W7 | 6/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | PRCP | P42785 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.38 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.38 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6872038 | 0.96 | TRPM8 (0.56) | TRPM8EPHX1POLBNAAAPRCP | |
| SCHEMBL6871778 | 0.94 | TRPM8 (0.55) | TRPM8EPHX1POLBNAAAPRCP | |
| SCHEMBL6868953 | 0.94 | TRPM8 (0.55) | TRPM8EPHX1POLBNAAAPRCP | |
| SCHEMBL18287153 | 0.94 | TRPM8 (0.55) | TRPM8EPHX1POLBNAAAPRCP | |
| SCHEMBL6862982 | 0.91 | TRPM8 (0.60) | TRPM8EPHX1TRPA1 | |
| SCHEMBL18547556 | 0.90 | TRPM8 (0.61) | TRPM8EPHX1POLBTRPA1 | |
| SCHEMBL18583870 | 0.90 | TRPM8 (0.61) | TRPM8EPHX1POLBTRPA1 | |
| SCHEMBL11418730 | 0.89 | TRPM8 (0.54) | TRPM8EPHX1TRPA1 | |
| SCHEMBL18583469 | 0.87 | EPHX1 (0.55) | TRPM8EPHX1TRPA1 | |
| Hydrochloric Acid SCHEMBL18547896 | 0.86 | EPHX1 (0.54) | TRPM8EPHX1TRPA1GNAI3GNAO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2533760-A1 | LIQUID COMPOSITION COMPRISING A NON-MENTHOL COOLING AGENT AND A THICKENER FOR TREATING A RESPIRATORY SYMPTOM | The Procter & Gamble Company (US) | 2012-12-19 | — | — | EP | claimed |
| WO-2011100267-A1 | LIQUID COMPOSITION COMPRISING A NON-MENTHOL COOLING AGENT AND A THICKENER FOR TREATING A RESPIRATORY SYMPTOM | THE PROCTER & GAMBLE COMPANY (US) | 2011-08-18 | — | — | WO | claimed |
| WO-2023248187-A1 | ORAL COMPOSITION COMPRISING A RECEPTOR MODULATOR | Nicoventures Trading Limited (GB) | 2023-12-28 | — | — | WO | disclosed |
| WO-2017048490-A1 | A PROCESS FOR MAKING A DETERGENT COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2017-03-23 | — | — | WO | disclosed |
| WO-2016094599-A1 | A PROCESS FOR MAKING A CONSUMER GOODS PRODUCT COMPRISING A BENEFIT DELIVERY COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2016-06-16 | — | — | WO | disclosed |
| WO-2016094600-A1 | A PROCESS FOR MAKING A CONSUMER GOODS PRODUCT COMPRISING A BENEFIT DELIVERY COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2016-06-16 | — | — | WO | disclosed |
| EP-2934119-A1 | INSECT REPELLENT CLEANING COMPOSITION | Henkel AG & Co. KGaA (DE) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014095541-A1 | INSECT REPELLENT CLEANING COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2014-06-26 | — | — | WO | disclosed |
| EP-1750525-A2 | PHYSIOLOGICAL COOLING COMPOSITIONS | Millennium Specialty Chemicals, Inc. (US) | 2007-02-14 | — | — | EP | disclosed |
| WO-2005117811-A2 | PHYSIOLOGICAL COOLING COMPOSITIONS | MILLENNIUM SPECIALTY CHEMICALS (US) | 2005-12-15 | — | — | WO | disclosed |
| EP-1311158-B1 | COMPOSITION HAVING INSECT REPELLENT CHARACTERISTICS | GIVAUDAN SA (CH) | 2004-08-11 | — | — | EP | disclosed |
| US-20040028714-A1 | Composition having insect repellent characteristics | GIVAUDAN SA (CH) | 2004-02-12 | — | — | US | disclosed |
| EP-1311158-A1 | COMPOSITION HAVING INSECT REPELLENT CHARACTERISTICS | Givaudan SA (CH) | 2003-05-21 | — | — | EP | disclosed |
| WO-2002015692-A1 | COMPOSITION HAVING INSECT REPELLENT CHARACTERISTICS | GIVAUDAN SA (CH) | 2002-02-28 | — | — | WO | disclosed |
| US-4391285-A | Smoking article | PHILIP MORRIS, INCORPORATED (US) | 1983-07-05 | — | — | US | disclosed |
| US-4347855-A | Method of making smoking articles | PHILIP MORRIS INCORPORATED (US) | 1982-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040028714-A1 | Composition having insect repellent characteristics | SUV39H1, PNMT, SUV39H2 | TRPM8 36/4885EPHX1 690/4885POLB 3532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.